Cascade screening of familial hypercholesterolemia must go on von Galema-Boers, J.M.H, Versmissen, J, Roeters van Lennep, H.W.O, Dusault-Wijkstra, J.E, Williams, M, Roeters van Lennep, J.E

Volltext

Underrepresentation of women in cardiovascular disease clinical Trials—What’s in a Name? von Spiering, A.E., van Ommen, A.M.L.N., Roeters van Lennep, J.E., Appelman, Y., Reue, K., Onland-Moret, N.C., den Ruijter, H.M.

Volltext

Lomitapide affects HDL composition and function von Yahya, R, Favari, E, Calabresi, L, Verhoeven, A.J.M, Zimetti, F, Adorni, M.P, Gomaraschi, M, Averna, M, Cefalù, A.B, Bernini, F, Sijbrands, E.J.G, Mulder, M.T, Roeters van Lennep, J.E

Volltext

LP(a) is not associated with c-imt or the presence of carotid plaques in statin treated fh or fch patients von Bos, S, Yayha, R, van den Oord, S.C.H, Schinkel, A.F.L, Sijbrands, E.J.G, Mulder, M.T, Roeters van Lennep, J.E

Volltext

LDL cholesterol targets rarely achieved in familial hypercholesterolemia patients: A sex and gender-specific analysis von Schreuder, M.M., Hamkour, S., Siegers, K.E., Holven, K.B., Johansen, A.K., van de Ree, M.A., Imholz, B., Boersma, E., Louters, L., Bogsrud, M.P., Retterstøl, K., Visseren, F.L.J., Roeters van Lennep, J.E., Koopal, C.

Volltext

Treatment of a compound heterozygous familial hypercholesterolemia patient with lomitapide von Yahya, R, Favari, E, Bos, S, Vongpromek, R, van der Zee, L, Touw, A, Zimetti, F, Adorn, M.P, Bernini, F, Verhoeven, A, Sijbrands, E.J.G, Mulder, M.T, Roeters van Lennep, J.E

Volltext

Efficacy & safety of PCSK9-inhibitors: A systematic review and meta-analysis of real-world data von Mulder, J.W.C.M., Steward, K., Galema-Boers, A.M.H., Boersma, E., Roeters Van Lennep, J.E.

Volltext

Lomitapide in the long-term real-world management of HoFH – effectiveness, tolerability, and hepatic safety data from the pan-European study von D'Erasmo, L., Steward, K., Di Costanzo, A., Boersma, E., Arca, M., Roeters Van Lennep, J.E.

Volltext

Sex differences in efficacy and side effects of proprotein convertase subtilisin / kexin 9 (PCSK9) inhibitors in real world data von Galema-Boers, A.M.H., Steward, K., Mulder, J.W.C.M., Roeters Van Lennep, J.E.

Volltext

P.23 Prophylaxis with low-dose low-molecular-weight-heparin during pregnancy and postpartum: is it effective? von Roeters van Lennep, J.E, Meijer, E, Klumper, F.J.C.M, Middeldorp, J.M, Bloemenkamp, K.W.M, Middeldorp, S

Volltext

Sex-specific temporal evolution of circulating biomarkers in patients with chronic heart failure with reduced ejection fraction von Schreuder, M.M., Schuurman, A., Akkerhuis, K.M., Constantinescu, A.A., Caliskan, K., van Ramshorst, J., Germans, T., Umans, V.A., Boersma, E., Roeters van Lennep, J.E., Kardys, I.

Volltext

Trajectories of metabolic risk factors and risk of new-onset atrial fibrillation among men and women von Lu, Z, Tilly, M.J, Aribas, E, Roeters Van Lennep, J.E, Ikram, M.A, De Groot, N.M.S, Van Rosmalen, J, Kavousi, M

Volltext

Prophylaxis with low‐dose low‐molecular‐weight heparin during pregnancy and postpartum: is it effective? von ROETERS VAN LENNEP, J. E., MEIJER, E., KLUMPER, F. J. C. M., MIDDELDORP, J. M., BLOEMENKAMP, K. W. M., MIDDELDORP, S.

Volltext

LDL-c response with different statin treatment intensities in fh patients: A sex-specific analysis von Schreuder, M.M., Holven, K.B., Johansen, A.K., Koopal, C., Van De Ree, M., Imholz, B., Boersma, E., Bogsrud, M.P., Retterstol, K., Visseren, F., Roeters Van Lennep, J.E.

Volltext

Patient-Reported Outcome Measures In Familial Hypercholesterolemia (Fh) Patients: Knowledge Is Health von Mulder, J., Galema-Boers, J.M.H., Hazelzet, J.A., Roeters van Lennep, J.E.

Volltext

Reporting of sex-specific outcomes in trials of interventions for cardiovascular disease: Has there been progress? von Schreuder, M.M., Boersma, E., Kavousi, M., Visser, L.E., Roos - Hesselink, J.W., Versmissen, J., Roeters van Lennep, J.E.

Volltext

Double-heterozygous autosomal dominant hypercholesterolemia: Clinical characterization of an underreported disease von Sjouke, B, Defesche, J.C, Hartgers, M.L, Wiegman, A, Roeters van Lennep, J.E, Kastelein, J.J.P, Hovingh, G.K

Volltext

The periconception maternal cardiovascular risk profile influences human embryonic growth trajectories in IVF/ICSI pregnancies von Wijnands, K.P.J., van Uitert, E.M., Roeters van Lennep, J.E., Koning, A.H.J., Mulders, A.G.M.G.J., Laven, J.S.E., Steegers, E.A.P., Steegers-Theunissen, R.P.M.

Volltext

[BP.03.02] ON THE ORIGIN AND DISAPPEARANCE OF SFLT-1 AND PLGF IN PREECLAMPSIA von Saleh, L., Van Den Meiracker, A.H., Geensen, R., Roeters Van Lennep, J.E., Duvekot, J.J., Verdonk, K., Steegers, E.A.P., Russcher, H., Danser, A.H.J., Visser, W.

Volltext

[PP.23.15] THE EVOLUTION OF SFLT-1/PLGF RATIO DURING PREGNANCY IN WOMEN WITH (SUSPECTED) PREECLAMPSIA von Saleh, L., van den Meiracker, A.H., Geensen, R., Lennep, J.E. Roeters van, Duvekot, J.J., Verdonk, K., Steegers, E.A.P., Russcher, H., Danser, A.H.J., Visser, W.

Volltext